At the RWEsearch Annual Summit 2024, hosted by Healthark Insights, Chris Cameron, Chief Scientific Officer at EVERSANA, emphasized that advancements in Real World Evidence will accelerate with ongoing learning and use of technology and AI.
Advanced breast cancer often comes with significant physical symptoms, such as pain and fatigue, as well as side effects from treatments. The diagnosis and treatment of advanced breast cancer can lead to anxiety, depression and stress.…
Because the EU Health Technology Assessment (HTA) regulation will take effect in January 2025, pharmaceutical and medical device companies must prepare for a new era in health technology evaluations. The Joint Clinical Assessment (JCA), a core…
Unlock the latest insights into AI-driven healthcare with APACMed’s 2024 Digital Health Reimbursement Policy Forum! This comprehensive white paper dives into key discussions from the event, where industry experts, policymakers, and thought leaders from across APAC,…
Are you interested in the latest developments in high-cost drug reforms across the EU4+UK markets? Our comprehensive paper, “Understanding Key Reforms for High-Cost Drugs in EU4+UK Markets,” delves into the intricate landscape of pharmaceutical pricing and…
Authors: Monica Gangwani, Executive Director India, Advisory Services, APAC Consulting; Gaurav Kolhekar, Senior Consultant, APAC Consulting; Utkarsh Sahu, Analyst, APAC Consulting India’s obesity market is rapidly expanding, driven by economic growth and lifestyle changes that have…
In today’s healthcare landscape, patients are no longer passive recipients of care. They are empowered, tech-savvy stakeholders who demand efficiency and transparency. Yet, despite advancements in consumer innovation, the healthcare system often leaves them frustrated with…
Are you interested in the rapidly evolving pharmaceutical landscape? Do you want to understand the paradigm shift in global commercialization strategies? If so, we have just the resource for you! Download our latest article titled “The…
As the pharmaceutical industry in the Asia-Pacific (APAC) region undergoes a digital transformation, the shift towards an omnichannel strategy is reshaping how companies engage with healthcare professionals (HCPs). “The Omnichannel Landscape in APAC’s Healthcare Industry,” authored…
In anticipation of Frontiers Health 2024, EVERSANA is delighted to reveal that several of our key experts will be speaking at this top-tier global health innovation conference! Scheduled for October 17-18th in Berlin, Germany, Frontiers Health…